Question

In non-compartmental analysis, which statement DOES NOT APPLY to Area under the first moment curve [AUMC]?

• A. It is the area under the plot of the product of concentration and time vs. time
• B. It is used to calculate the mean residence time (MRT) of the drug
• C. It is used to calculate the bioavailability and clearance rate
• D. It is sensitive to the terminal phase of drug elimination

Hint:

To differentiate between $AUC$ and $AUMC$: - $AUC \implies \text{Units: } \text{mass} \cdot \text{time} / \text{volume} \implies \text{Yields Clearance \& Bioavailability}$ - $AUMC \implies \text{Units: } \text{mass} \cdot \text{time}^2 / \text{volume} \implies \text{Yields Mean Residence Time (MRT)}$

Answer 1

The Correct Option is C

Concept: Non-compartmental analysis (NCA) relies heavily on statistical moments to characterize the concentration-time profile of a drug without assuming a specific compartmental model arrangement.
• Zero-th Moment ($AUC$): Area Under the plasma Concentration-time curve. \[ AUC = \int_{0}^{\infty} C \cdot dt \] It is used directly to determine total systemic clearance ($Cl = \text{Dose}/AUC$) and absolute bioavailability ($F$).
• First Moment ($AUMC$): Area Under the first Moment Curve. \[ AUMC = \int_{0}^{\infty} t \cdot C \cdot dt \] It represents the area under the curve obtained by plotting the product of concentration and time ($C \times t$) against time ($t$).

Step 1: Evaluate Statement A and Statement B.
Statement A correctly defines the mathematical definition of $AUMC$ as $\int t \cdot C \cdot dt$. Statement B is also mathematically valid because the Mean Residence Time ($MRT$), which represents the average time a drug molecule spends inside the body, is directly computed as the ratio of the first moment to the zero-th moment: \[ MRT = \frac{AUMC}{AUC} \]

Step 2: Evaluate Statement C and Statement D.
Systemic clearance ($Cl$) and bioavailability ($F$) are derived strictly using the zero-th moment ($AUC$) via the relationship: \[ Cl = \frac{F \cdot \text{Dose}}{AUC} \] Hence, $AUMC$ is not directly utilized to compute clearance and bioavailability independently, making Statement C incorrect and thus the correct answer to this "DOES NOT APPLY" question. Statement D is correct because the multiplication by time ($t$) weighs the later time points heavily, making $AUMC$ highly sensitive to terminal phase modifications.